Construction and Comprehensive Prognostic Analysis of a Novel Immune-Related lncRNA Signature and Immune Landscape in Gastric Cancer

Figure 10

Clinical significance of the risk model in immune landscape. Boxplot was used to visualize the difference of HLA and immune check points between the high-risk group and the low-risk group ((a) and (b)). Enrichment of 13 immune-related pathway was evaluated by using ssGSEA (c). Patients in low-risk group with positive status of CTLA4 or PD-1 have superior immunotherapy scores than high-risk group (d). TIDE prediction score indicated that low-risk patients might be more sensitive to immunotherapy (e).

(a)

(b)

(c)

(d)

(e)